Search
Close this search box.

Mikrobiomik

Biopharmaceutical company dedicated to the research and development of medicines based on the human microbiome. www.mikrobiomik.net

The challenge

Seeking an alternative that simplifies the bacterial cell counting process for Mikrobiomik’s faecal microbiota tablets. This counting process is a central task in Mikrobiomik’s activity and its automation would enable them to save staff hours, the cost of consumables and standardise the counting process.

The solution

To this end, a comparative analysis of the different options available was carried out in order to find a simple, reproducible and reliable method that best suits the company’s needs. Thanks to the analysis of alternatives carried out by GAIKER, an automated solution for microbial counting was found, through which Mikrobiomik hopes to achieve more standardised and reproducible results, as well as reducing the time spent by its workers on this counting process.

Results

  • Automation of the counting process
  • Speed, sensitivity and accuracy of results
  • More standardised and reproducible results
  • Reduction in the time spent by workers on the counting process

What is said about our Centre?

"We are working with GAIKER to develop a new analysis methodology and replace part of our process in order to be more efficient. We are very pleased with the results obtained and with the working methodology they have developed for us. We would like to highlight their professionalism and willingness to help. We would definitely work with them again for future projects."

Juan Basterra Cossio - CEO

Mikrobiomik Healthcare Company SL,

Chemical-Pharmaceutical

Biological medicines based on the human microbiome.

Would you like to talk to an expert?